Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Kaneko, Naoki, Kuo, Hsiao-Hsuan, Boucau, Julie, Farmer, Jocelyn R., Allard-Chamard, Hugues, Mahajan, Vinay S., Piechocka-Trocha, Alicja, Lefteri, Kristina +43 more·2020·Cell

Cited by (735)

Items 101–200 of 735

  1. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
    Juanjie Tang, Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Hollie Genser, Hana Golding, Surender Khurana · 2021 · Nature Communications
  2. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence
    Sushma Boppana, Kai Qin, Jacob K. Files, Ronnie M. Russell, Regina Stoltz, Frédéric Bibollet‐Ruche, Anju Bansal, Nathan B. Erdmann, Beatrice H. Hahn, Paul Goepfert · 2021 · PLoS Pathogens
  3. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
    Melanie Ricke‐Hoch, Elisabeth Stelling, Lisa Laßwitz, Antonia P. Gunesch, Martina Kasten, Francisco José Zapatero Belinchón, Graham Brogden, Gisa Gerold, Thomas Pietschmann, Virginie Montiel et al. · 2021 · PLoS ONE
  4. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
    Qin Xu, Pedro Milanez‐Almeida, Andrew J. Martins, Andrea J. Radtke, Kenneth B. Hoehn, Cihan Oguz, Jinguo Chen, Can Liu, Juanjie Tang, Gabrielle Grubbs et al. · 2022 · Nature Immunology
  5. Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
    Abayasingam, Arunasingam, Balachandran, Harikrishnan, Agapiou, David, Hammoud, Mohamed, Rodrigo, Chaturaka, Keoshkerian, Elizabeth, Li, Hui, Brasher, Nicholas A., Christ, Daniel, Rouet, Romain et al. · 2021 · Cell Reports Medicine
  6. Repurposing approved drugs for cancer therapy
    Schein, Catherine H · 2021 · British Medical Bulletin
  7. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
    Jim B. Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, Victoria Louise Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross et al. · 2020 · Journal of Clinical Investigation
  8. The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2
    Georg Bauer · 2021 · International Journal of Infectious Diseases
  9. Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
    Paulina Kapłonek, Chuangqi Wang, Yannic C. Bartsch, Stephanie Fischinger, Matthew J. Gorman, Kathryn A. Bowman, Jaewon Kang, Diana Dayal, Patrick Martin, Radosław P. Nowak et al. · 2021 · Science Immunology
  10. The role of B cells in COVID-19 infection and vaccination
    Shiru Chen, Fei Guan, Fabio Candotti, Kamel Benlagha, Niels Olsen Saraiva Câmara, Andrés A. Herrada, Louisa Katherine James, Jiahui Lei, Heather Miller, Masato Kubo et al. · 2022 · Frontiers in Immunology
  11. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
    L. Ruhl, I. Pink, J. Kühne, K. Beushausen, J. Keil, S. Christoph, A. Sauer, Lennart Boblitz, J. Schmidt, Sascha David et al. · 2021 · Signal Transduction and Targeted Therapy
  12. Molecular mechanisms controlling age‐associated B cells in autoimmunity*
    Swati Phalke, Juan Rivera‐Correa, Daniel Jenkins, Danny Flores-Castro, Ευγενία Γιαννοπούλου, Alessandra B. Pernis · 2022 · Immunological Reviews
  13. The immune response to SARS-CoV-2 in people with HIV
    Maxine A. Höft, Wendy A. Burgers, Catherine Riou · 2023 · Cellular and Molecular Immunology
  14. Titanium Dioxide Nanoparticle: A Comprehensive Review on Synthesis, Applications and Toxicity
    Rakhi Chandoliya, Shivika Sharma, Vikas Sharma, Rohit Joshi, Iyyakkannu Sivanesan · 2024 · Plants
  15. Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
    Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Osamu Akasaka, Michiko Koga, Eisuke Adachi, Makoto Saito, Ichiro Nakachi et al. · 2021 · Science Advances
  16. Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease
    Ryusuke Munemura, Takashi Maehara, Yuka Murakami, Risako Koga, Ryuichi Aoyagi, Naoki Kaneko, Atsushi Doi, Cory A. Perugino, Emanuel Della‐Torre, Takako Saeki et al. · 2022 · Journal of Allergy and Clinical Immunology
  17. Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency
    Thomas Magg, Tsubasa Okano, Lars M. König, Daniel F. R. Boehmer, Samantha L. Schwartz, Kento Inoue, Jennifer R. Heimall, Francesco Licciardi, Julia Ley‐Zaporozhan, Ronald M. Ferdman et al. · 2021 · Science Immunology
  18. Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
    Noah J. Silverstein, Yetao Wang, Zachary Manickas-Hill, Claudia Carbone, Ann Dauphin, Brittany P. Boribong, Maggie Loiselle, Jameson Davis, Maureen M. Leonard, Leticia Kuri-Cervantes et al. · 2022 · eLife
  19. Transcription tipping points for T follicular helper cell and T-helper 1 cell fate commitment
    Amania A. Sheikh, Joanna R. Groom · 2020 · Cellular and Molecular Immunology
  20. Longitudinal Characterization of Circulating Neutrophils Uncovers Distinct Phenotypes Associated with Disease Severity in Hospitalized COVID-19 Patients
    Thomas J. LaSalle, Anna L. K. Gonye, Samuel S. Freeman, Paulina Kapłonek, Irena Gushterova, Kyle R. Kays, Kasidet Manakongtreecheep, Jessica Tantivit, Maricarmen Rojas-López, Brian C. Russo et al. · 2021 · Cell Reports Medicine
  21. Lymphopenia in sepsis—an acquired immunodeficiency?
    Simon R. Finfer, Balasubramanian Venkatesh, Richard S. Hotchkiss, Sarah Christina Sasson · 2022 · Immunology and Cell Biology
  22. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
    Ali Hamady, JinJu Lee, Zuzanna Loboda · 2021 · Infection
  23. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
    Louisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius J. Schmidt, Sascha David et al. · 2021 · Zurich Open Repository and Archive (University of Zurich)
  24. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration
    Krista L. Newell, Deanna C. Clemmer, Justin B. Cox, Yetunde I. Kayode, Victoria Zoccoli-Rodriguez, Harry E. Taylor, Timothy P. Endy, Joel R. Wilmore, Gary M. Winslow · 2021 · PLoS ONE
  25. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
    Deepta Bhattacharya · 2022 · Immunity
  26. Immune imprinting and next-generation coronavirus vaccines
    Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, Andrew C. Y. Chan, Jonathan Luke Heeney · 2023 · Nature Microbiology
  27. Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice
    Patricia E. Zerra, Seema R. Patel, Ryan Philip Jajosky, Connie Maridith Arthur, James W. McCoy, Jerry William Lynn Allen, Satheesh Chonat, Ross M. Fasano, John D. Roback, Cassandra D. Josephson et al. · 2021 · Blood
  28. The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
    Christine Harrer, Ferdinand Otto, Richard Friedrich Radlberger, Tobias Moser, Georg Pilz, Peter Wipfler, Andrea Harrer · 2022 · Cells
  29. T-cell dysregulation in COVID-19
    Bahire Kalfaoglu, José Almeida‐Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono · 2020 · Biochemical and Biophysical Research Communications
  30. B Cells in Systemic Lupus Erythematosus
    Susan Canny, Shaun W. Jackson · 2021 · Rheumatic Disease Clinics of North America
  31. COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
    Ying Liu, Junyan Han, Xin Li, Danying Chen, Xuesen Zhao, Yaruo Qiu, Leidan Zhang, Jing Xiao, Bei Li, Hongxin Zhao · 2021 · Vaccines
  32. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19
    Nils H. Wildner, Parimah Ahmadi, Sophia Schulte, Franziska Brauneck, Matin Kohsar, Marc Lütgehetmann, Claudia Beisel, Marylyn M. Addo, Friedrich Haag, Julian Schulze zur Wiesch · 2020 · Journal of Leukocyte Biology
  33. IL-12 induces a B cell-intrinsic IL-12/IFNγ feed-forward loop promoting extrafollicular B cell responses
    Rebecca A. Elsner, Shuchi Smita, Mark Jay Shlomchik · 2024 · Nature Immunology
  34. A comprehensive profile of TCF1+ progenitor and TCF1− terminally exhausted PD-1+CD8+ T cells in head and neck squamous cell carcinoma: implications for prognosis and immunotherapy
    Di-Kan Wang, Juan Fang, Shuqiong Wen, Qunxing Li, Jinming Wang, Lisa Yang, W. Dai, Huanzi Lu, Junyi Guo, Z. Shan et al. · 2022 · International Journal of Oral Science
  35. Immunosenescence and inflamm-ageing in COVID-19
    Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, Hamid Kooshki, Mozafar Mohammadi, Jafar Amani, Nima Rezaei · 2022 · Ageing Research Reviews
  36. Anti-cytokine autoantibodies: mechanistic insights and disease associations
    Aristine Cheng, Steven M. Holland · 2023 · Nature reviews. Immunology
  37. Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
    А. С. Головкин, Olga Kalinina, Vadim A. Bezrukikh, Arthur D. Aquino, Ekaterina Konstantinovna Zaikova, Tatyana L. Karonova, Olesya Melnik, Elena Vasilieva, Igor Vladimirovich Kudryavtsev · 2021 · Viruses
  38. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
    Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
  39. Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
    Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, Sara Hasler, Christian Pou, Ziyang Tan, Sarah Adamo, Miro E. Raeber, Esther Bächli, Alain Rudiger et al. · 2022 · Allergy
  40. Host Recovery from Respiratory Viral Infection
    Xiaoqin Wei, Harish Narasimhan, Bibo Zhu, Jie Sun · 2023 · Annual Review of Immunology
  41. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
    Matthew K. Siggins, Ryan S. Thwaites, Peter Openshaw · 2021 · Trends in Microbiology
  42. Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation
    Adi Biram, Jingjing Liu, Hadas Hezroni, Natalia Davidzohn, Dominik Schmiedel, Eman Khatib-Massalha, Montaser Haddad, Amalie Grenov, Sacha Lebon, Tomer‐Meir Salame et al. · 2022 · Immunity
  43. COVID-19: Immunology, Immunopathogenesis and Potential Therapies
    Asha Bhardwaj, Leena Sapra, Chaman Saini, Zaffar Azam, Pradyumna Kumar Mishra, Bhupendra Verma, Gyan C. Mishra, Rupesh Kumar Srivastava · 2021 · International Reviews of Immunology
  44. COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
    Philip W. Askenase · 2020 · Journal of Extracellular Vesicles
  45. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination
    Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen Kelvin Tuong, Lorinda Turner, Kelvin Hunter, Pehuén Pereyra Gerber, Myra D.T. Hosmillo, Christoph Hess et al. · 2022 · Cell Reports
  46. Immune responses in mildly versus critically ill COVID-19 patients
    Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, Maryam Noroozi, Seppo Meri, Kurosh Kalantar · 2023 · Frontiers in Immunology
  47. Immune Response to Respiratory Viral Infections
    Antonella Gambadauro, Francesca Galletta, Alessandra Li Pomi, Sara Manti, Giovanni Piedimonte · 2024 · International Journal of Molecular Sciences
  48. COVID-19 and rheumatoid arthritis
    Kristin M. D'Silva, Zachary Scott Wallace · 2021 · Current Opinion in Rheumatology
  49. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
    Elsa Brunet‐Ratnasingham, Sai Priya Anand, Pierre Gantner, Alina Dyachenko, Gaël Moquin‐Beaudry, Nathalie Brassard, Guillaume Beaudoin-Bussières, Amélie Pagliuzza, Romain Gasser, Mehdi Benlarbi et al. · 2021 · Science Advances
  50. Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
    Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory A. Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja K. Trocha, Kristina Lefteri et al. · 2022 · Clinical Immunology
  51. SARS-CoV-2 epitope–specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability
    Ryan W. Nelson, Yuezhou Chen, Olivia L. Venezia, Richard M. Majerus, Daniel Sanghoon Shin, MGH COVID-19 Collection & Processing Team, Mary N Carrington, Xu G. Yu, Duane R. Wesemann, James J. Moon et al. · 2022 · Science Immunology
  52. Kinetics of antibody responses dictate COVID-19 outcome
    Carolina Gonçalves de Oliveira Lucas, Jon Klein, Maria E. Sundaram, Feimei Liu, Patrick Wong, Júlio Dos Santos Silva, Tianyang Mao, Ji Eun Oh, Maria Tokuyama, Peiwen Lu et al. · 2020 · medRxiv
  53. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
    Alberto Beretta, Martin P Cranage, Donato Zipeto · 2020 · Frontiers in Immunology
  54. Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice
    Cecília B. Cavazzoni, Benjamin L. Hanson, Manuel Alfredo Podestà, Elsa D. Bechu, Rachel L. Clement, Hengcheng Zhang, Joe Daccache, Tamara Reyes Robles, Erik C. Hett, Kalpit A. Vora et al. · 2022 · Cell Reports
  55. Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19
    Maria G. Byazrova, Gaukhar M. Yusubalieva, Anna A. Spiridonova, Grigory Aleksandrovich Efimov, Dmitriy V. Mazurov, Konstantin O. Baranov, Vladimir P. Baklaushev, Alexander V. Filatov · 2021 · Clinical & Translational Immunology
  56. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
    Ludmila Müller, Svetlana Di Benedetto · 2021 · International Journal of Molecular Sciences
  57. TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease
    А. А. Савченко, Елена Петровна Тихонова, Igor Vladimirovich Kudryavtsev, Dmitry Anatolievich Kudlay, I.A. Korsunsky, V. D. Belenyuk, А. Г. Борисов · 2022 · Viruses
  58. COVID‐19 immunopathology: From acute diseases to chronic sequelae
    Mohd Arish, Wei Guo Qian, Harish Narasimhan, Jie Sun · 2022 · Journal of Medical Virology
  59. Vaccination versus infection with SARS‐CoV‐2: Establishment of a high avidity IgG response versus incomplete avidity maturation
    Friedhelm Struck, Patrick A. Schreiner, Eva Staschik, Karin Wochinz‐Richter, Sarah Schulz, Erwin Soutschek, Manfred Motz, Georg Bauer · 2021 · Journal of Medical Virology
  60. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
    Javier García‐Abellán, Marta Fernández‐González, Sergio Padilla, José Alberto García, Vanesa Agulló, Valle Lozano, Nuria Ena, Lidia García-Sánchez, Félix Gutiérrez, Mar Masiá · 2022 · Frontiers in Immunology
  61. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19
    Dong‐Min Kim, Yuri Kim, Jun-Won Seo, Joo-Yeon Lee, Uni Park, Na‐Young Ha, Jaemoon Koh, Hyoree Park, Jaewon Lee, Hyo‐Jin Ro et al. · 2021 · Cell Reports
  62. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
    Jennifer Chen, Ryan Dz-Wei Chow, Eric Song, Tianyang Mao, Benjamin Israelow, Kathy Kamath, Joel D. Bozekowski, Winston A. Haynes, Renata B. Filler, Bridget L. Menasché et al. · 2022 · Science Immunology
  63. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
    David S. Kim, Sarah Rowland‐Jones, Ester Gea‐Mallorquí · 2020 · Frontiers in Immunology
  64. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
  65. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency
    Sudhir Gupta, Houfen Su, Tejal Narsai, Sudhanshu Agrawal · 2021 · International Archives of Allergy and Immunology
  66. Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19
    Hugues Allard‐Chamard, Naoki Kaneko, Alice Bertocchi, Na Sun, Julie Boucau, Hsiao-Hsuan Kuo, Jocelyn R. Farmer, Cory A. Perugino, Vinay S. Mahajan, Samuel J. H. Murphy et al. · 2023 · Cell Reports
  67. Tumor-Associated Neutrophils Drive B-cell Recruitment and Their Differentiation to Plasma Cells
    Merav E. Shaul, Asaf Zlotnik, Einat Tidhar, Asaf Schwartz, Ludovica Arpinati, Naomi Kaisar-Iluz, Sojod Mahroum, Inbal Mishalian, Zvi Gregorio Fridlender · 2021 · Cancer Immunology Research
  68. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
  69. B cell contribution to immunometabolic dysfunction and impaired immune responses in obesity
    Kristīne Oļeiņika, Baiba Šlisere, Diego Catalán, Elizabeth C. Rosser · 2022 · Clinical & Experimental Immunology
  70. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
    I. Zanoni · 2021 · Current Opinion in Virology
  71. NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
    Mina Thabet Kelleni · 2021 · Expert Review of Anti-infective Therapy
  72. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
    Dawei Cui, Yuan Tang, Qi Jiang, Daixi Jiang, Yun Zhang, Yan Lv, Dandan Xu, Jian Wu, Jue Xie, Chengping Wen et al. · 2021 · Frontiers in Immunology
  73. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
    Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estévez, Ferdinando Nicoletti, Francisco Javier Turrubiates‐Hernández, Katia Mangano, José Francisco Muñóz-Valle · 2021 · International Journal of Immunopathology and Pharmacology
  74. Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
    Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, Li Chen, Xuemei He et al. · 2023 · Nature Communications
  75. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
    Igor Vladimirovich Kudryavtsev, Artem Rubinstein, А. С. Головкин, Olga Kalinina, Kirill Vasilyev, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
  76. Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
    T. Vanwolleghem, Tom Adomati, S. Van Hees, H. Janssen · 2021 · JHEP Reports
  77. Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay
    Chang Sheng Zhou, Ge Bu, Yong Chang Sun, Cuiping Ren, Mingsheng Qu, Yufeng Gao, Yulin Zhu, Linding Wang, Liang Sun, Yan Liu · 2020 · Journal of Medical Virology
  78. Acupuncture modulates immunity in sepsis: Toward a science-based protocol
    Weixing X. Pan, Arthur Yin Fan, Shaozong Chen, Sarah Faggert Alemi · 2021 · Autonomic Neuroscience
  79. Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans
    Danika Lea Hill, Carly E. Whyte, Silvia Innocentin, Jia Le Lee, James Dooley, Jiong Wang, Eddie A James, James Christopher Lee, William W Kwok, Martin Stuart Zand et al. · 2021 · eLife
  80. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
    A. Talla, S. Vasaikar, Maria P. Lemos, Z. Moodie, Mark-Phillip Lee Pebworth, Kathy E. Henderson, Kristen W. Cohen, Julie L. Czartoski, Li-Lin Lai, M. Suthar et al. · 2021 · bioRxiv
  81. COVID ‐19 and plasma cells: Is there long‐lived protection?*
    Doan C. Nguyen, Pedro A. Lamothe, Matthew Charles Woodruff, Ankur Singh Saini, Caterina Elisa Faliti, Igñacio Sanz, Frances Eun-Hyung Lee · 2022 · Immunological Reviews
  82. Aerosol pulmonary immune engineering
    Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole A. Gill, Kartik Bomb, Catherine A. Fromen · 2023 · Advanced Drug Delivery Reviews
  83. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
    Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, Nader Bagheri, Davood Bashash · 2021 · International Immunopharmacology
  84. Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators
    Doan C. Nguyen, Meixue Duan, Mohammad Ali, Ariel M. Ley, Igñacio Sanz, Frances Eun-Hyung Lee · 2021 · Immunological Reviews
  85. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
    Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, Ignazio Stefano Piras, Matthew J. Huentelman, Christine M. Belden, Danielle Goldfarb, David Shprecher, Alireza Atri, Charles H. Adler et al. · 2022 · Journal of Neuropathology & Experimental Neurology
  86. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
    Manish K. Dhawan, Ali Ahmed Rabaan, Mahmoud M. Fawarah, Souad A. Almuthree, Roua Abdullah Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi et al. · 2023 · Vaccines
  87. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
    Anne‐Gaëlle Goubet, Agathe Dubuisson, Arthur Géraud, F.X. Danlos, Safae Aarab Terrisse, Carolina Alves Costa Silva, Damien Drubay, Lea Touri, Marion Picard, Marine Mazzenga et al. · 2021 · Cell Death and Differentiation
  88. Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
    Naomi J. Patel, Kristin M. D’Silva, Tiffany Y. T. Hsu, Michael A. DiIorio, Xiaoqing Fu, C. Cook, Lauren C. Prisco, Lily K. Martin, Kathleen M.M. Vanni, Alessandra Zaccardelli et al. · 2021 · ACR Open Rheumatology
  89. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities
    Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, Majid Pakdin, Seyed Mahdi Zarezadeh, Arezoo Faridzadeh, Sarina Entezari, Arina Ansari, Mohadeseh Poudineh, Niloofar Deravi · 2022 · Frontiers in Molecular Biosciences
  90. Use of machine learning to identify a T cell response to SARS-CoV-2
    M. Saad Shoukat, Andrew D. Foers, Stephen Woodmansey, Shelley C. Evans, Anna Fowler, Elizabeth J. Soilleux · 2021 · Cell Reports Medicine
  91. SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing
    Bobin Mi, Yuan Xiong, Chenming Zhang, Wu Zhou, Lang Chen, Faqi Cao, Fenghua Chen, Zhi Geng, Adriana Christine Panayi, Yun Sun et al. · 2021 · International Journal of Biological Sciences
  92. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
    Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, Yuki Ozaki, Nicolas Sax, Yuichi Maeda, Yasuhiro Kato et al. · 2021 · The Journal of Experimental Medicine
  93. SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
    John Tyler Sandberg, Renata Varnaitė, Wanda Christ, Puran Chen, Jagadeeswara Rao Muvva, Kimia T. Maleki, Marina García, Majda Dzidic, Elin Folkesson, Magdalena Skagerberg et al. · 2021 · Clinical & Translational Immunology
  94. PD-1highCXCR5–CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection
    Hiromitsu Asashima, Subhasis Mohanty, Michela Comi, William E. Ruff, Kenneth B. Hoehn, Patrick Wong, Jon Klein, Carolina Gonçalves de Oliveira Lucas, Inessa Cohen, Sarah Coffey et al. · 2023 · Cell Reports
  95. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
    Joseph Yunis, Kirsty Renfree Short, Di Yu · 2023 · Trends in Microbiology
  96. Immunology of COVID ‐19
    Harald Brüssow · 2020 · Environmental Microbiology
  97. Lessons in antiviral immunity
    Jennifer L. Hope, Linda M. Bradley · 2021 · Science
  98. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?
    Danny David Jonigk, Christopher Werlein, Till Acker, Martin Aepfelbacher, Kerstin Amann, Gustavo Bruno Baretton, Peter Barth, Rainer Maria Bohle, Andreas Büttner, Reinhard Büttner et al. · 2022 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  99. Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells
    Krisztián Csomós, Boglárka Ujházi, Péter Blazsó, Jose L. Herrera, Christopher M. Tipton, Tomoki Kawai, Sumai Gordon, Maryssa Ellison, Kevin Wu, Matthew T. Stowell et al. · 2022 · Nature Immunology
  100. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
    Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Hossein Aghamollaei, Mahdi Fasihi‐Ramandi, Gholam Hossein Alishiri, Alireza Shahriary, Kazem Hassanpour, Mahdi Tat, Gholamreza Farnoosh · 2021 · European Journal of Pharmacology